The invention relates to a process for prepg. a compd. I in particular obeticholic acid (II) and intermediates suitable for its synthesis.  A process for the prepn. of II comprises the use of hyodeoxycholic acid (III) as the starting material, Wittig reaction of oxocholate IV [wherein; Ra is H or an (un)​substituted linear or branched C1-​6-​alkyl, or an (un)​substituted aryl; Rb is H; and, Rc is OH or O-​PG; wherein PG is an alc. protecting group;]​.  [Or, Rb is OR1 and Rc is OR2; wherein each of R1 and R2, which are the same or different, is a C1-​6-​alkyl group; or, R1 and R2 taken together form a (CH2)​n chain; wherein n is 2 or 3,​] with EtPh3P+Br-​;allylic oxidn. of ethylidenechenodeoxycholate V; and hydrogenation, stereoselective redn. and sapon. of ethyldioxocholate VI.

Method for preparing a farnesoid X receptor agonist obeticholic acid from hyodeoxycholic acid

IULIANO, ANNA;
2017-01-01

Abstract

The invention relates to a process for prepg. a compd. I in particular obeticholic acid (II) and intermediates suitable for its synthesis.  A process for the prepn. of II comprises the use of hyodeoxycholic acid (III) as the starting material, Wittig reaction of oxocholate IV [wherein; Ra is H or an (un)​substituted linear or branched C1-​6-​alkyl, or an (un)​substituted aryl; Rb is H; and, Rc is OH or O-​PG; wherein PG is an alc. protecting group;]​.  [Or, Rb is OR1 and Rc is OR2; wherein each of R1 and R2, which are the same or different, is a C1-​6-​alkyl group; or, R1 and R2 taken together form a (CH2)​n chain; wherein n is 2 or 3,​] with EtPh3P+Br-​;allylic oxidn. of ethylidenechenodeoxycholate V; and hydrogenation, stereoselective redn. and sapon. of ethyldioxocholate VI.
2017
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/911383
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact